Cerebral Amyloid Angiopathy: An Undeniable Small Vessel Disease

키워드

참고문헌 (94)

1. Zhang-Nunes SX, "The cerebral beta-amyloid angiopathies : hereditary and sporadic", Brain Pathol, 16, pp.30~39 (2006)
2. Viswanathan A, "Cerebral amyloid angiopathy in the elderly", Ann Neurol, 70, pp.871~880 (2011)
3. Boyle PA, "Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons", Neurology, 85, pp.1930~1936 (2015)
4. Banerjee G, "The increasing impact of cerebral amyloid angiopathy : essential new insights for clinical practice", J Neurol Neurosurg Psychiatry, 88, pp.982~994 (2017)
5. Jaunmuktane Z, "Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery", Acta Neuropathol, 135, pp.671~679 (2018)
6. Banerjee G, "Iatrogenic cerebral amyloid angiopathy : an emerging clinical phenomenon", J Neurol Neurosurg Psychiatry, 93, pp.693~700 (2022)
7. Yamada M, "Cerebral amyloid angiopathy : emerging concepts", J Stroke, 17, pp.17~30 (2015)
8. Kamp JA, "Amyloid β in hereditary cerebral hemorrhage with amyloidosis-Dutch type", Rev Neurosci, 25, pp.641~651 (2014)
9. Ristori E, "New insights into blood-brain barrier maintenance : the homeostatic role of β-amyloid precursor protein in cerebral vasculature", Front Physiol, 11, pp.1056~ (2020)
10. Levy E, "Stroke in icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases", J Exp Med, 169, pp.1771~1778 (1989)
11. Ghiso J, "Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein(cystatin C)", Proc Natl Acad Sci U S A, 83, pp.2974~2978 (1986)
12. Koemans EA, "Sex differences in onset and progression of cerebral amyloid angiopathy", Stroke, 54, pp.306~314 (2023)
13. Pantoni L, "Cerebral small vessel disease : from pathogenesis and clinical characteristics to therapeutic challenges", Lancet Neurol, 9, pp.689~701 (2010)
14. Thal DR, "Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease", Acta Neuropathol, 129, pp.167~182 (2015)
15. DeSimone CV, "Cerebral amyloid angiopathy : diagnosis, clinical implications, and management strategies in atrial fibrillation", J Am Coll Cardiol, 70, pp.1173~1182 (2017)
16. Thal DR, "Two types of sporadic cerebral amyloid angiopathy", J Neuropathol Exp Neurol, 61, pp.282~293 (2002)
17. Thal DR, "Vascular pathology in Alzheimer disease : correlation of cerebral amyloid angiopathy and arteriosclerosis", lipohyalinosis with cognitive decline, 2003, pp.62, 1287~1301
18. Charidimou A, "Enlarged perivascular spaces as a marker of underlying arteriopathy in intracerebral haemorrhage : a multicentre MRI cohort study", J Neurol Neurosurg Psychiatry, 84, pp.624~629 (2013)
19. Falcone GJ, "Genetics of spontaneous intracerebral hemorrhage", Stroke, 48, pp.3420~3424 (2017)
20. Carpenter AM, "Genetic risk factors for spontaneous intracerebral haemorrhage", Nat Rev Neurol, 12, pp.40~49 (2016)
21. Serrano-Pozo A, "APOE and Alzheimer’s disease : advances in genetics, pathophysiology, and therapeutic approaches", Lancet Neurol, 20, pp.68~80 (2021)
22. Rannikmäe K, "Genetics of cerebral amyloid angiopathy : systematic review and meta-analysis", J Neurol Neurosurg Psychiatry, 84, pp.901~908 (2013)
23. Lamar M, "APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults", Alzheimers Dement, 15, pp.258~266 (2019)
24. Chu S, "Cerebral amyloid angiopathy(CAA)-related inflammation : comparison of inflammatory CAA and amyloid-β-related angiitis", J Alzheimers Dis, 51, pp.525~532 (2016)
25. Chwalisz BK, "Cerebral amyloid angiopathy and related inflammatory disorders", J Neurol Sci, 424, pp.117425~ (2021)
26. Kirshner HS, "The inflammatory form of cerebral amyloid angiopathy or"cerebral amyloid angiopathy-related inflammation"(CAARI)", Curr Neurol Neurosci Rep, 15, pp.54~ (2015)
27. Theodorou A, "Cerebral amyloid angiopathy-related inflammation : a single-center experience and a literature review", J Clin Med, 11, pp.6731~ (2022)
28. Scolding NJ, "Abeta-related angiitis : primary angiitis of the central nervous system associated with cerebral amyloid angiopathy", Brain, 128, pp.500~515 (2005)
29. Auriel E, "The pathophysiology and clinical presentation of cerebral amyloid angiopathy", Curr Atheroscler Rep, 14, pp.343~350 (2012)
30. Renard D, "Cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation : comparison of hemorrhagic and DWI MRI features", J Alzheimers Dis, 64, pp.1113~1121 (2018)
31. Zhou H, "Endothelial BACE1 impairs cerebral small vessels via tight junctions and eNOS", Circ Res, 130, pp.1321~1341 (2022)
32. Ihara M, "Endothelial BACE1 : bridging the gap between hypertension and Alzheimer’s disease", Circ Res, 130, pp.1342~1344 (2022)
33. Koelsch G, "BACE1 function and inhibition : implications of intervention in the amyloid pathway of Alzheimer’s disease pathology", Molecules, 22, pp.1723~ (2017)
34. Charidimou A, "Emerging concepts in sporadic cerebral amyloid angiopathy", Brain, 140, pp.1829~1850 (2017)
35. Lovelock CE, "Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006 : a population-based study", Lancet Neurol, 6, pp.487~493 (2007)
36. Chao CP, "Cerebral amyloid angiopathy : CT and MR imaging findings", Radiographics, 26, pp.1517~1531 (2006)
37. "Prat Neurol FMC", 2016, 239~249
38. Block F, "Cerebral amyloid angiopathy in stroke medicine", Dtsch Arztebl Int, 114, pp.37~42 (2017)
39. Hirohata M, "Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy", Eur J Neurol, 17, pp.823~829 (2010)
40. Charidimou A, "Cerebral amyloid angiopathy-related transient focal neurological episodes(CAA-TFNEs) : a well-defined clinical-radiological syndrome", J Neurol Sci, 406, pp.116496~ (2019)
41. Charidimou A, "Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy : multicentre magnetic resonance imaging cohort study and meta-analysis", Stroke, 43, pp.2324~2330 (2012)
42. Smith EE, "Cerebral amyloid angiopathy-related transient focal neurologic episodes", Neurology, 97, pp.231~238 (2021)
43. Charidimou A, "Cortical superficial siderosis : detection and clinical significance in cerebral amyloid angiopathy and related conditions", Brain, 138, pp.2126~2139 (2015)
44. Charidimou A, "Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy", Neurology, 81, pp.626~632 (2013)
45. Vales-Montero M, "Cerebral amyloid angiopathy-related transient focal neurological episodes : a transient ischemic attack mimic with an increased risk of intracranial hemorrhage", J Neurol Sci, 406, pp.116452~ (2019)
46. Ellis RJ, "Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease : the CERAD experience, Part XV", Neurology, 46, pp.1592~1596 (1996)
47. Arvanitakis Z, "Cerebral amyloid angiopathy pathology and cognitive domains in older persons", Ann Neurol, 69, pp.320~327 (2011)
48. Durrani R, "Mediators of cognitive impairment in cerebral amyloid angiopathy", Int J Stroke, 18, pp.78~84 (2023)
49. Rabin JS, "Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline", Brain, 145, pp.2823~2833 (2022)
50. Charidimou A, "Total magnetic resonance imaging burden of small vessel disease in cerebral amyloid angiopathy : an imaging-pathologic study of concept validation", JAMA Neurol, 73, pp.994~1001 (2016)
51. Appleton JP, "Imaging markers of small vessel disease and brain frailty, and outcomes in acute stroke", Neurology, 94, pp.e439~e452 (2020)
52. Horn MJ, "Cerebellar atrophy and its implications on gait in cerebral amyloid angiopathy", J Neurol Neurosurg Psychiatry, 93, pp.802~807 (2022)
53. Pasi M, "Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease", Neurology, 88, pp.2162~2168 (2017)
54. Werring DJ, "Cerebral microbleeds and vascular cognitive impairment", J Neurol Sci, 299(1-2), pp.P131~P135 (2010)
55. Greenberg SM, "Cerebral microbleeds : a guide to detection and interpretation", Lancet Neurol, 8, pp.165~174 (2009)
56. Polyakova TA, "Cerebral microbleeds in cerebrovascular and neurodegenerative diseases with cognitive impairment", Zh Nevrol Psikhiatr Im S S Korsakova, 116, pp.19~27 (2016)
57. Vernooij MW, "Prevalence and risk factors of cerebral microbleeds : the Rotterdam Scan Study", Neurology, 70, pp.1208~1214 (2008)
58. Wang S, "Superficial white matter microstructure affects processing speed in cerebral small vessel disease", Hum Brain Mapp, 43, pp.5310~5325 (2022)
59. Chen J, "Alzheimer’s Disease Neuroimaging Initiative. Bilateral distance partition of periventricular and deep white matter hyperintensities:performance of the method in the aging brain", Acad Radiol, 28, pp.1699~1708 (2021)
60. Xu M, "Total burden of cerebral small vessel disease in recurrent ICH versus first-ever ICH", Aging Dis, 10, pp.570~577 (2019)
61. Debette S, "The clinical importance of white matter hyperintensities on brain magnetic resonance imaging : systematic review and meta-analysis", BMJ, 341, pp.c3666~ (2010)
62. Lampe L, "Lesion location matters : the relationships between white matter hyperintensities on cognition in the healthy elderly", J Cereb Blood Flow Metab, 39, pp.36~43 (2019)
63. Brown R, "Rate of, and risk factors for, white matter hyperintensity growth : a systematic review and meta-analysis with implications for clinical trial design", J Neurol Neurosurg Psychiatry, 92, pp.1271~1277 (2021)
64. Charidimou A, "Acute convexity subarachnoid haemorrhage and cortical superficial siderosis in probable cerebral amyloid angiopathy without lobar haemorrhage", J Neurol Neurosurg Psychiatry, 89, pp.397~403 (2018)
65. Raposo N, "Convexity subarachnoid hemorrhage in lobar intracerebral hemorrhage : a prognostic marker", Neurology, 94, pp.e968~e977 (2020)
66. Markus HS, "Cerebral small vessel disease : recent advances and future directions", Int J Stroke, 18, pp.4~14 (2023)
67. Yu L, "Perivascular spaces, glymphatic system and MR", Front Neurol, 13, pp.844938~ (2022)
68. Evans TE, "Determinants of perivascular spaces in the general population : a pooled cohort analysis of individual participant data", Neurology, 100, pp.e107~e122 (2023)
69. Ramirez J, "Imaging the perivascular space as a potential biomarker of neurovascular and neurodegenerative diseases", Cell Mol Neurobiol, 36, pp.289~299 (2016)
70. Inglese M, "Dilated perivascular spaces : hallmarks of mild traumatic brain injury", AJNR Am J Neuroradiol, 26, pp.719~724 (2005)
71. Kwee RM, "Virchow-Robin spaces at MR imaging", Radiographics, 27, pp.1071~1086 (2007)
72. Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration", Lancet Neurol, 12, pp.822~838 (2013)
73. Passiak BS, "Perivascular spaces contribute to cognition beyond other small vessel disease markers", Neurology, 92, pp.e1309~e1321 (2019)
74. Perosa V, "Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex", Acta Neuropathol, 143, pp.331~348 (2022)
75. Montagne A, "APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline", Nature, 581, pp.71~76 (2020)
76. Smith EE, "Cerebral microinfarcts : the invisible lesions", Lancet Neurol, 11, pp.272~282 (2012)
77. Corrada MM, "Microinfarcts are common and strongly related to dementia in the oldestold : the 90+ study", Alzheimers Dement, 12, pp.900~908 (2016)
78. van Veluw SJ, "Microbleed and microinfarct detection in amyloid angiopathy : a high-resolution MRI-histopathology study", Brain, 139, pp.3151~3162 (2016)
79. van Dalen JW, "Cortical microinfarcts detected in vivo on 3 Tesla MRI : clinical and radiological correlates", Stroke, 46, pp.255~257 (2015)
80. Zwartbol MH, "Cortical cerebral microinfarcts on 7T MRI : risk factors, neuroimaging correlates and cognitive functioning-the Medea-7T study", J Cereb Blood Flow Metab, 41, pp.3127~3138 (2021)
81. Hilal S, "Cortical cerebral microinfarcts on 3T MRI : a novel marker of cerebrovascular disease", Neurology, 87, pp.1583~1590 (2016)
82. Greenberg SM, "Diagnosis of cerebral amyloid angiopathy : evolution of the Boston criteria", Stroke, 49, pp.491~497 (2018)
83. Linn J, "Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy", Neurology, 74, pp.1346~1350 (2010)
84. Charidimou A, "The Boston criteria version 2. 0 for cerebral amyloid angiopathy : a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study", Lancet Neurol, 21, pp.714~725 (2022)
85. Rodrigues MA, "The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy : model development and diagnostic test accuracy study", Lancet Neurol, 17, pp.232~240 (2018)
86. Chung KK, "Cerebral amyloid angiopathy related inflammation : three case reports and a review", J Neurol Neurosurg Psychiatry, 82, pp.20~26 (2011)
87. Auriel E, "Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation", JAMA Neurol, 73, pp.197~202 (2016)
88. Hemphill JC 3rd, "Guidelines for the management of spontaneous intracerebral hemorrhage : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2015, pp.46, 2032~2060
89. Moullaali TJ, "Early lowering of blood pressure after acute intracerebral haemorrhage : a systematic review and metaanalysis of individual patient data", J Neurol Neurosurg Psychiatry, 93, pp.6~13 (2022)
90. Rehni AK, "Red Blood cell microparticles limit hematoma growth in intracerebral hemorrhage", Stroke, 53, pp.3182~3191 (2022)
91. Tsai HH, "Functional investigation of meningeal lymphatic system in experimental intracerebral hemorrhage", Stroke, 53, pp.987~998 (2022)
92. Xiong M, "APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function", Sci Transl Med, 13, pp.eabd7522~ (2021)
93. Zhou G, "Fruquintinib", HMPL-013 ameliorates cognitive impairments and pathology in a mouse model of cerebral amyloid angiopathy(CAA), 2023, pp.939, 175446~
94. Regenhardt RW, "Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathyrelated inflammation", JAMA Neurol, 77, pp.1261~1269 (2020)

관련 논문AI추천